Vicki Sato, Director at Revvity, holds 118.04K shares in Denali Therapeutics (Ticker: DNLI), holds 1.32M shares in Vir Biotechnology (Ticker: VIR), holds 101.10K shares in Allogene Therapeutics (Ticker: ALLO).
Vicki Sato latest transaction was an Uninformative Sell of $30.47K.
What was Vicki Sato's most profitable transaction?
Vicki Sato’s most profitable transaction was an Informative Buy of RVTY stock on April 27, 2016. The return on the trade was 5.80%.
What is Vicki Sato's role in Revvity?
Vicki Sato's role in Revvity is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.